Naftifine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00735 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cutaneous candidiasis | KG + DL |
| 2 | Majocchi granuloma | KG + DL |
| 3 | ectothrix infectious disease | KG + DL |
| 4 | pityriasis versicolor | KG + DL |
| 5 | endothrix infectious disease | KG + DL |
| 6 | dermatophytosis of scalp or beard | KG + DL |
| 7 | superficial mycosis | KG + DL |
| 8 | tinea profunda | KG + DL |
| 9 | blastomycosis | KG + DL |
| 10 | nail infection | KG + DL |
| 11 | ophthalmic herpes zoster | KG + DL |
| 12 | vernal conjunctivitis | KG + DL |
| 13 | tinea manuum | KG + DL |
| 14 | Freiberg disease | KG + DL |
| 15 | papillary conjunctivitis | KG + DL |
| 16 | orbital cellulitis | KG + DL |
| 17 | non-syndromic brachydactyly of toes | KG + DL |
| 18 | skin disease caused by infection | KG + DL |
| 19 | infectious mononucleosis | KG + DL |
| 20 | infectious anterior uveitis | KG + DL |
| 21 | skin infection | KG + DL |
| 22 | atopic conjunctivitis | KG + DL |
| 23 | limb disorder | KG + DL |
| 24 | postinfectious vasculitis | KG + DL |
| 25 | post-bacterial disorder | KG + DL |
| 26 | post-infectious syndrome | KG + DL |
| 27 | rosacea conjunctivitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.